|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/127 | (2006.01) |
| A61K 39/00 | (2006.01) | ||
| A61K 48/00 | (2006.01) |
| (11) | Number of the document | 3427723 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18171522.8 |
| Date of filing the European patent application | 2013-03-25 | |
| (97) | Date of publication of the European application | 2019-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation | 2020-12-28 |
| (30) | Number | Date | Country code |
| PCT/EP2012/0013 | 2012-03-26 | WO |
| (72) |
SAHIN, Ugur, DE
HAAS, Heinrich, DE
KREITER, Sebastian, DE
DIKEN, Mustafa, DE
FRITZ, Daniel, DE
MENG, Martin, DE
KRANZ, Lena Mareen, DE
REUTER, Kerstin, DE
|
| (73) |
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb,
Freiligrathstrasse 12, 55131 Mainz,
DE
BioNTech SE, An der Goldgrube 12, 55131 Mainz, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | RNR kompozicija, skirta imunoterapijai |
| RNA FORMULATION FOR IMMUNOTHERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 13 | 289.00 EUR |
| 2026-03-25 |